BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 10733167)

  • 1. Alloreactive cytotoxic CD4+ responses elicited by cytomegalovirus-infected endothelial cells: role of MHC class I antigens.
    Weinberg A; Zhang L; Hayward AR
    Viral Immunol; 2000; 13(1):37-47. PubMed ID: 10733167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NK recognition of cytomegalovirus-infected endothelial cells depends on viral replication and MHC class I expression.
    Weinberg A; Zhang L; Tuder RM
    Viral Immunol; 1996; 9(2):131-40. PubMed ID: 8822629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus (CMV)-specific lysis of CMV-infected target cells can be mediated by both NK-like and virus-specific cytotoxic T lymphocytes.
    Gehrz RC; Rutzick SR
    Clin Exp Immunol; 1985 Jul; 61(1):80-9. PubMed ID: 2994924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine-mediated induction of endothelial adhesion molecule and histocompatibility leukocyte antigen expression by cytomegalovirus-activated T cells.
    Waldman WJ; Knight DA
    Am J Pathol; 1996 Jan; 148(1):105-19. PubMed ID: 8546198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immune reaction to human cytomegalovirus].
    Ito M
    Nihon Rinsho; 1998 Jan; 56(1):62-8. PubMed ID: 9465666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DR-restricted cytotoxicity of cytomegalovirus-infected monocytes mediated by Leu-3-positive T cells.
    Lindsley MD; Torpey DJ; Rinaldo CR
    J Immunol; 1986 Apr; 136(8):3045-51. PubMed ID: 2420881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic T-lymphocyte responses to cytomegalovirus in normal and simian immunodeficiency virus-infected rhesus macaques.
    Kaur A; Daniel MD; Hempel D; Lee-Parritz D; Hirsch MS; Johnson RP
    J Virol; 1996 Nov; 70(11):7725-33. PubMed ID: 8892893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants.
    Lucas KG; Sun Q; Burton RL; Tilden A; Vaughan WP; Carabasi M; Salzman D; Ship A
    Hum Gene Ther; 2000 Jul; 11(10):1453-63. PubMed ID: 10910142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
    Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
    Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
    Muraoka S
    Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous ex vivo expansion of cytomegalovirus and Epstein-Barr virus-specific cytotoxic T lymphocytes using B-lymphoblastoid cell lines expressing cytomegalovirus pp65.
    Sun Q; Pollok KE; Burton RL; Dai LJ; Britt W; Emanuel DJ; Lucas KG
    Blood; 1999 Nov; 94(9):3242-50. PubMed ID: 10556213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cytomegalovirus-specific CD4+ cytotoxic T lymphocytes from seropositive or negative healthy subjects or stem cell transplant recipients.
    Tazume K; Hagihara M; Gansuvd B; Higuchi A; Ueda Y; Hirabayashi K; Hojo M; Tanabe A; Okamoto A; Kato S; Hotta T
    Exp Hematol; 2004 Jan; 32(1):95-103. PubMed ID: 14725906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression.
    Riddell SR; Rabin M; Geballe AP; Britt WJ; Greenberg PD
    J Immunol; 1991 Apr; 146(8):2795-804. PubMed ID: 1707922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
    Bishop DK; Shelby J; Eichwald EJ
    Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vitro model of T cell activation by autologous cytomegalovirus (CMV)-infected human adult endothelial cells: contribution of CMV-enhanced endothelial ICAM-1.
    Waldman WJ; Knight DA; Huang EH
    J Immunol; 1998 Apr; 160(7):3143-51. PubMed ID: 9531269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4(+)CD8(dim) T lymphocytes exhibit enhanced cytokine expression, proliferation and cytotoxic activity in response to HCMV and HIV-1 antigens.
    Suni MA; Ghanekar SA; Houck DW; Maecker HT; Wormsley SB; Picker LJ; Moss RB; Maino VC
    Eur J Immunol; 2001 Aug; 31(8):2512-20. PubMed ID: 11500836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA.
    Fletcher JM; Prentice HG; Grundy JE
    J Immunol; 1998 Sep; 161(5):2365-74. PubMed ID: 9725232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro induction of endothelial HLA class II antigen expression by cytomegalovirus-activated CD4+ T cells.
    Waldman WJ; Knight DA; Adams PW; Orosz CG; Sedmak DD
    Transplantation; 1993 Dec; 56(6):1504-12. PubMed ID: 7904091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical-scale isolation of 'minimally manipulated' cytomegalovirus-specific donor lymphocytes for the treatment of refractory cytomegalovirus disease.
    Odendahl M; Grigoleit GU; Bönig H; Neuenhahn M; Albrecht J; Anderl F; Germeroth L; Schmitz M; Bornhäuser M; Einsele H; Seifried E; Busch DH; Tonn T
    Cytotherapy; 2014 Sep; 16(9):1245-56. PubMed ID: 25108651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes.
    McLaughlin-Taylor E; Pande H; Forman SJ; Tanamachi B; Li CR; Zaia JA; Greenberg PD; Riddell SR
    J Med Virol; 1994 May; 43(1):103-10. PubMed ID: 8083644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.